Skip to main content
Clinical Trials/NCT01621841
NCT01621841
Completed
Not Applicable

Analysis of Visual Pathways in Glaucoma Patients Using a 3tesla-MRI

University Hospital, Bordeaux1 site in 1 country114 target enrollmentJune 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Glaucoma
Sponsor
University Hospital, Bordeaux
Enrollment
114
Locations
1
Primary Endpoint
fractional anisotropy
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Glaucoma is a neurodegenerative disease representing the second cause of blindness worldwide. IOP (Intra occular pressure) is the most common risk factor, but not the only one as it is observed for normal tension glaucoma. Some studies have reported lesions of the optical pathways on MRI examination MRI 3T (Magnetic Resonance Imaging 3 Telsa), by increasing spatial resolution and DTI (diffusion tensor Imaging)with fractional anisotropy could help us to analyze visual pathways and to determine the association with neurodegenerative diseases as Alzheimer.

The investigators propose to compare volume and structure of the visual pathways between glaucoma patients and healthy subjects matched on age and sex.

Glaucoma is a neurodegenerative disease characterized by loss of retinal ganglion cells, visual field deterioration and optic nerve cupping. Some studies have suggested that all the visual pathways could be damaged in glaucoma. Recently, a German study proved a significant reduction of volume of the optic radiations in glaucoma versus healthy subjects in MRI 3T. Some authors have also suggested that glaucoma could share similarities with the other neurodegenerative diseases like Alzheimer's disease. MRI 3T and DTI allow studying visual pathways with a high level of spatial resolution.Fractional anisotropy is a tag of microstructure.

Registry
clinicaltrials.gov
Start Date
June 2012
End Date
November 2013
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Bordeaux
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • for cases : Age over 40 years-old, glaucomatous lesion of the optic nerve head with cup/disc ratio, visual field loss, and minimental state superior or equal to 28/30
  • for healthy subjects/ matched on age and sex, no individual or familial history of glaucoma, IOP less than 21mmHG, minimental state superior or equal to 28/30

Exclusion Criteria

  • Ocular hypertension, optic nerve disease, visual field loss, diabetes, Horton disease, ocular diseases, immunologic diseases, neuropsychiatric diseases, MRI contraindication (pace maker)

Outcomes

Primary Outcomes

fractional anisotropy

Time Frame: Inclusion

Secondary Outcomes

  • volume of retrochiasmatic grey matter(Inclusion)
  • global atrophy(inclusion)
  • hyper intensities white matter(inclusion)

Study Sites (1)

Loading locations...

Similar Trials